Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines.

Tsou PS, Rabquer BJ, Ohara RA, Stinson WA, Campbell PL, Amin MA, Balogh B, Zakhem G, Renauer PA, Lozier A, Arasu E, Haines GK 3rd, Kahaleh B, Schiopu E, Khanna D, Koch AE.

Rheumatology (Oxford). 2016 Apr;55(4):745-54. doi: 10.1093/rheumatology/kev399. Epub 2015 Dec 24.

PMID:
26705326
2.

Epigenetics and systemic sclerosis.

Altorok N, Kahaleh B.

Semin Immunopathol. 2015 Sep;37(5):453-62. doi: 10.1007/s00281-015-0504-6. Epub 2015 Jul 11.

PMID:
26162437
3.

Endothelial dysfunction in systemic sclerosis.

Altorok N, Wang Y, Kahaleh B.

Curr Opin Rheumatol. 2014 Nov;26(6):615-20. doi: 10.1097/BOR.0000000000000112. Review.

PMID:
25191994
4.

Epigenetics, the holy grail in the pathogenesis of systemic sclerosis.

Altorok N, Almeshal N, Wang Y, Kahaleh B.

Rheumatology (Oxford). 2015 Oct;54(10):1759-70. doi: 10.1093/rheumatology/keu155. Epub 2014 Apr 16. Review.

PMID:
24740406
5.

International consensus criteria for the diagnosis of Raynaud's phenomenon.

Maverakis E, Patel F, Kronenberg DG, Chung L, Fiorentino D, Allanore Y, Guiducci S, Hesselstrand R, Hummers LK, Duong C, Kahaleh B, Macgregor A, Matucci-Cerinic M, Wollheim FA, Mayes MD, Gershwin ME.

J Autoimmun. 2014 Feb-Mar;48-49:60-5. doi: 10.1016/j.jaut.2014.01.020. Epub 2014 Feb 1. Review.

6.

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE.

Arthritis Rheum. 2013 Nov;65(11):2737-47. doi: 10.1002/art.38098. Epub 2013 Oct 3.

7.

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.

van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Ellen Csuka M, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE.

Ann Rheum Dis. 2013 Nov;72(11):1747-55. doi: 10.1136/annrheumdis-2013-204424.

PMID:
24092682
8.

Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma.

Wang Y, Kahaleh B.

J Cell Mol Med. 2013 Oct;17(10):1291-9. doi: 10.1111/jcmm.12105. Epub 2013 Jul 16.

9.

Review: evidence that systemic sclerosis is a vascular disease.

Matucci-Cerinic M, Kahaleh B, Wigley FM.

Arthritis Rheum. 2013 Aug;65(8):1953-62. doi: 10.1002/art.37988. Review. No abstract available.

10.

Cardiovascular disease in autoimmune rheumatic diseases.

Hollan I, Meroni PL, Ahearn JM, Cohen Tervaert JW, Curran S, Goodyear CS, Hestad KA, Kahaleh B, Riggio M, Shields K, Wasko MC.

Autoimmun Rev. 2013 Aug;12(10):1004-15. doi: 10.1016/j.autrev.2013.03.013. Epub 2013 Mar 27. Review.

PMID:
23541482
11.

Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.

Serratì S, Chillà A, Laurenzana A, Margheri F, Giannoni E, Magnelli L, Chiarugi P, Dotor J, Feijoo E, Bazzichi L, Bombardieri S, Kahaleh B, Fibbi G, Del Rosso M.

Arthritis Rheum. 2013 Jan;65(1):258-69. doi: 10.1002/art.37705.

12.

Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise.

Fransen J, Johnson SR, van den Hoogen F, Baron M, Allanore Y, Carreira PE, Czirják L, Denton CP, Distler O, Furst DE, Gabrielli A, Herrick A, Inanc M, Kahaleh B, Kowal-Bielecka O, Medsger TA Jr, Mueller-Ladner U, Riemekasten G, Sierakowski S, Valentini G, Veale D, Vonk MC, Walker U, Chung L, Clements PJ, Collier DH, Csuka ME, Jimenez S, Merkel PA, Seibold JR, Silver R, Steen V, Tyndall A, Matucci-Cerinic M, Pope JE, Khanna D.

Arthritis Care Res (Hoboken). 2012 Mar;64(3):351-7. doi: 10.1002/acr.20679.

13.

Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis.

Rabquer BJ, Tsou PS, Hou Y, Thirunavukkarasu E, Haines GK 3rd, Impens AJ, Phillips K, Kahaleh B, Seibold JR, Koch AE.

Arthritis Res Ther. 2011 Feb 8;13(1):R18. doi: 10.1186/ar3242.

14.

Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12.

Margheri F, Serratì S, Lapucci A, Chillà A, Bazzichi L, Bombardieri S, Kahaleh B, Calorini L, Bianchini F, Fibbi G, Del Rosso M.

Arthritis Rheum. 2010 Aug;62(8):2488-98. doi: 10.1002/art.27522. Erratum in: Arthritis Rheumatol. 2015 May;67(8):2175.

15.

MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.

Chung L, Shapiro L, Fiorentino D, Baron M, Shanahan J, Sule S, Hsu V, Rothfield N, Steen V, Martin RW, Smith E, Mayes M, Simms R, Pope J, Kahaleh B, Csuka ME, Gruber B, Collier D, Sweiss N, Gilbert A, Dechow FJ, Gregory J, Wigley FM.

Arthritis Rheum. 2009 Mar;60(3):870-7. doi: 10.1002/art.24351.

16.

Statistics and the relationship of clinical research to clinical practice.

Khuder SA, Kahaleh B.

J Rheumatol. 2009 Feb;36(2):219-20. doi: 10.3899/jrheum.081206. No abstract available.

PMID:
19208555
17.

The microvascular endothelium in scleroderma.

Kahaleh B.

Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v14-5. doi: 10.1093/rheumatology/ken279. Review.

18.

Vascular disease in scleroderma: mechanisms of vascular injury.

Kahaleh B.

Rheum Dis Clin North Am. 2008 Feb;34(1):57-71; vi. doi: 10.1016/j.rdc.2007.12.004. Review.

PMID:
18329532
19.

Outcome measurements in scleroderma: results from a delphi exercise.

Gazi H, Pope JE, Clements P, Medsger TA, Martin RW, Merkel PA, Kahaleh B, Wollheim FA, Baron M, Csuka ME, Emery P, Belch JF, Hayat S, Lally EV, Korn JH, Czirjak L, Herrick A, Voskuyl AE, Bruehlmann P, Inanc M, Furst DE, Black C, Ellman MH, Moreland LW, Rothfield NF, Hsu V, Mayes M, McKown KM, Krieg T, Siebold JR.

J Rheumatol. 2007 Mar;34(3):501-9. Epub 2007 Feb 1.

PMID:
17299843
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk